Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vetter Dedicates New Facility In Suburban Chicago
Vetter has added new 24,000-square-foot facility at the Illinois Science + Technology Park in Skokie, which is expected to enable life-sciences firms to streamline their early development process
Vetter has added new 24,000-square-foot facility at the Illinois Science + Technology Park in Skokie, which is expected to enable life-sciences firms to streamline their early development process
University of Leeds has a new laboratory, which will focus on making small scale process development more greener, cheaper and effective. The laboratory was built with an investment
Mocon is introducing film cells as optional add-ons to its recently launched OpTech – O2 Platinum analyzer. The additional capability sets the performance bar higher for the unit
Schreiner MediPharm’s transparent-Hologram-Seal is set to provide evidence against tampering and counterfeiting of drugs. The hologram has been helpful in ensuring packaged pharmaceutical safety of drugs. Reportedly, the
Addex Pharmaceuticals has extended its research collaboration with Merck & Co, through an affiliate, for an additional year. The collaboration is focused on developing positive allosteric modulators (PAM)
Dyax has received FDA approval to market Kalbitor, indicated for the treatment of hereditary angioedema in patients 16 years and above. Angioedema is the rapid swelling of the
Health Enhancement Products (HEPI) has reported that based on observations of ProAlgaZyme (PAZ) activity during tests for inflammation management, Wayne State University School of Medicine professor of pathology
Ipsen has announced that its partner Roche has disclosed the results of the second and third of eight T-emerge phase III studies in patients with diabetes for Taspoglutide.
UMF has introduced Micrillon, the first patented and rechargeable antimicrobial-polymer chemistry developed to help combat healthcare-associated infections (HAIs), that are picked up by patients during hospital stays. Developed
Alexion Pharmaceuticals has provided updates on the regulatory review and approval of Alexion’s Rhode Island manufacturing facility (ARIMF) in Smithfield, Rhode Island as a second source of supply